Related Experiment Video
Updated: Jul 30, 2026

A Simple Protocol for Platelet-mediated Clumping of Plasmodium falciparum-infected Erythrocytes in a Resource Poor Setting
Published on: May 16, 2013
[Migraine with pleocytosis: a case of atypical progression]
S Santos1, B Sierra Bergua, I de los Mártires Armingol
1Hospital Clinico Universitario Lozano Blesa, Zaragoza, España. ssantosl@yahoo.com
Aims:
Migraine with cerebrospinal fluid pleocytosis is a clinical pattern consisting in intermittent headaches accompanied by episodes of transient neurological deficit and lymphocytic pleocytosis, which last for varying lengths of time and have a spontaneous resolution. We describe the case of migraine with pleocytosis (MP) with atypical progression that responded well to corticoids.
Case Report:
A 27 year old male with no familial or personal history of migraine who began with bouts of intense headaches that were preceded by neurological deficit (dysphasia and hemiparesis of the right hand side) lasting varying amounts of time (including hours). The serial study of cerebrospinal fluid (CSF) revealed a notable degree of lymphocytosis (400/mm3) with increased intracranial pressure (ICP) (> 30 mmHg). The other explorations that were performed (microbiological study of CSF and blood, humoral and cellular immunity, MR angiography and thyroid hormones, among others) were all normal. The neurological exploration carried out in the following days revealed a mild paresis of the right lateral rectus muscle, which was attributed to the intracranial hypertension and which clearly disabled the patient. As a consequence of the recurrence of the seizures and the long lasting increase in ICP, therapy was begun with 1 mg/kg/day of prednisone, at a descending rate; clinical remission and normalisation of the CSF was achieved within a period of two months.
Discussion:
We describe this case of MP because of how atypical the progression was (paresis of the right abducent nerve secondary to the increase in ICP) and the possibility of associating corticoids in cases in which the benignity of the entity is in doubt.
Insights
This case study highlights a rare form of migraine with cerebrospinal fluid pleocytosis presenting with atypical neurological deficits. Corticosteroid treatment proved effective in managing symptoms and normalizing cerebrospinal fluid in this migraine variant.
Area of Science:
- Neurology
- Neuroimmunology
Background:
- Migraine with cerebrospinal fluid pleocytosis (MP) is characterized by headaches, transient neurological deficits, and lymphocytic pleocytosis.
- This condition typically resolves spontaneously.
Observation:
- A 27-year-old male presented with severe headaches and transient neurological deficits including dysphasia and hemiparesis.
- Cerebrospinal fluid analysis revealed significant lymphocytosis and elevated intracranial pressure (ICP).
- Atypical progression included right lateral rectus muscle paresis secondary to intracranial hypertension.
Findings:
- Standard investigations for infectious, autoimmune, and vascular causes were negative.
- Treatment with prednisone (1 mg/kg/day) led to clinical remission and normalization of CSF parameters within two months.
- The patient experienced resolution of neurological deficits and headaches.
Implications:
- This case suggests that corticosteroids may be a viable treatment option for atypical presentations of migraine with pleocytosis.
- The findings challenge the assumption of benignity in all MP cases, especially those with unusual progression.
- Further research into the immunomodulatory aspects of MP and corticosteroid efficacy is warranted.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Atypical Pneumonia
Malaria
Bacterial Meningitis II: Pathophysiology
Encephalitis l: Introduction
Brain Abscess l: Introduction

